首页|超滤治疗老年心力衰竭合并衰弱患者的有效性及安全性

超滤治疗老年心力衰竭合并衰弱患者的有效性及安全性

扫码查看
目的 探讨超滤治疗老年心力衰竭(心衰)合并衰弱患者的有效性及安全性.方法 88例老年心衰合并衰弱的住院患者随机分为常规组和超滤组,各44例.常规组给予药物治疗,超滤组在药物治疗的基础上进行超滤治疗,但在超滤治疗期间不使用利尿剂.比较2组疗效评价指标:治疗48 h后患者体质量、N末端B型利钠肽原(NT-proBNP),治疗48 h及1周后呼吸困难难度评分、住院时间、3个月内再次住院率.安全性评价指标:治疗48 h后患者血肌酐、血尿素氮、血钠、血钾,治疗1周后患者血肌酐.结果 疗效评价指标:2组患者治疗48 h后体质量、NT-proBNP均较治疗前降低(P<0.05),治疗前后2组体质量、NT-proBNP差异均无统计学意义(P>0.05);2组治疗48 h后患者呼吸困难难度评分均较治疗前升高,治疗1周后降低,超滤组治疗48 h后呼吸困难难度评分高于常规组(P<0.05);超滤组住院时间和3个月内再住院率均低于常规组(P<0.05).安全性评价指标:治疗前及治疗48 h后2组血尿素氮、血钠差异均无统计学意义(P>0.05),超滤组治疗48 h后血钾高于常规组(P<0.05);常规组治疗前后血肌酐无明显变化(P>0.05);超滤组治疗1周后血肌酐低于治疗前及治疗48 h,且低于常规组(P<0.05).结论 超滤治疗老年心衰合并衰弱是一种安全有效的治疗方法.
Efficacy and safety of ultrafiltration in the treatment for elderly patients with heart failure and frailty
Objective To investigate the efficacy and safety of ultrafiltration therapy in elderly patients with congestive heart failure(CHF)and frailty.Methods A total of 88 hospitalized elderly patients with CHF and frailty were randomly assigned to the ultrafiltration group(n=44)and the control group(n=44).The control group treated with standard drug therapy.The ultrafiltration group treated with ultrafiltration,however,diuretics were not used during ultrafiltration treatment.Efficacy assessment was compared between the two groups,including patient body weight,N-terminal pro-brain natriuretic peptide(NT-proBNP)levels at 48 hours after treatment,dyspnea severity scores at 48 hours and 1 week after treatment,hospitalization duration and readmission rate within 3 months.Safety assessment parameters included serum creatinine,urea nitrogen,Na+and K+concentration at 48 hours after treatment and creatinine level 1 week after treatment.Results Efficacy assessment indicated that at 48 hours after treatment,both groups showed a significant reduction in patient body weight and NT-proBNP levels compared to pre-treatment levels(P<0.05).However,there were no significant difference in body weight and NT-proBNP levels before and after treatment between the two groups(P>0.05).Dyspnea severity scores for both groups increased at 48 hours after treatment,then decreased at 1 week after treatment.The ultrafiltration group exhibited higher dyspnea severity scores than that of the control group at 48 hours after treatment(P<0.05).The length of hospital stay and the rate of re-hospitalization within 3 months were lower in the ultrafiltration group compared to those of the control group(P<0.05).Safety assessment revealed that there were no significant differences in serum urea nitrogen and Na+levels before and 48 hours after treatment between the two groups(P>0.05).However,serum K+levels were higher after 48-hours treatment in the ultrafiltration group than those of the control group(P<0.05).There were no significant changes in creatinine levels before and after treatment in the control group(P>0.05),while creatinine levels were lower 1 week after treatment in the ultrafiltration group compared to those of pre-treatment and 48 hours after treatment,and were lower than those of the control group(P<0.05).Conclusion Ultrafiltration is a safe and effective method for elderly patients with CHF and frailty.

heart failurefrailtyagedultrafiltration

徐斌、诸赟、陈浩、朱红俊、高枫、夏丛奕、钟玲、苏伟

展开 >

无锡市中医医院心血管内科(邮编 214071)

心力衰竭 衰弱 老年人 超滤

无锡市中医药管理局科技项目重点项目无锡市科技发展指导性计划(医疗卫生)项目无锡市"太湖人才计划"医疗卫生高层次人才项目(2020年度)

ZYZD01CSZON1618

2024

天津医药
天津市医学科学技术信息研究所

天津医药

CSTPCD
影响因子:1.107
ISSN:0253-9896
年,卷(期):2024.52(7)
  • 5